Department of Gynaecology, Tivoli Hospital, La Louvière, Belgium.
Department of Gynaecology, Epicura Hospital, Hornu, Belgium.
Am J Case Rep. 2024 Aug 23;25:e944365. doi: 10.12659/AJCR.944365.
BACKGROUND Perivascular epithelioid cell tumor (PEComa) is usually a benign perivascular tumor that expresses both melanocytic and myogenic cell markers. We report 2 cases of advanced malignant uterine perivascular epithelioid cell tumor (PEComa) in a 74-year-old woman and a 50-year-old woman undergoing surgery in our center. CASE REPORT Case 1: A 74-year-old woman presented with a painful and massive abdominal mass. The imaging revealed a 19-cm necrotic mass close to the mesentery, a suspicious lesion in the uterus, and a probable liver metastasis. The pathological diagnosis was quite difficult with mixed features of leiomyosarcoma and PEComa with an uncommon immunohistochemistry staining pattern. Therefore, we gave a diagnosis of sarcoma with PEComa-like features. Case 2: A 50-year-old woman with metrorrhagia and abdominal pain. Imaging revealed a 7-cm mass in the uterus and suspicious metastatic lesions in the lung and the liver. The immunohistochemistry pattern was typical, with a strong positivity of Human Melanoma Black-45 (HMB-45) and focal positivity of H-Caldesmon. The patient benefited from targeted adjuvant therapy (MTOR inhibitor-based), with 8-month a follow-up showing no recurrence for this Grade IV PEComa mutated for TP53, ATRX, and TSC1. CONCLUSIONS We have report 2 cases of metastatic PEComa with different clinicopathological features. An overlap remains between characteristics of PEComas and smooth-muscle tumors. At present, there are no known pathognomonic findings or specific diagnostic markers.
血管周上皮样细胞瘤(PEComa)通常是一种良性的血管周肿瘤,表达黑色素细胞和肌细胞标志物。我们报告了 2 例在我院接受手术的 74 岁女性和 50 岁女性的晚期恶性子宫血管周上皮样细胞瘤(PEComa)病例。
病例 1:一名 74 岁女性因腹痛性、巨大腹部肿块就诊。影像学检查显示肠系膜附近有一个 19cm 的坏死肿块、子宫可疑病变和可能的肝转移。病理诊断颇具难度,具有平滑肌肉瘤和 PEComa 的混合特征,免疫组织化学染色模式罕见。因此,我们诊断为具有 PEComa 样特征的肉瘤。
病例 2:一名 50 岁女性因月经过多和腹痛就诊。影像学检查显示子宫内有一个 7cm 的肿块和可疑的肺部和肝脏转移病灶。免疫组织化学模式典型,人黑色素瘤黑 45(HMB-45)强阳性,H-Caldesmon 局灶阳性。患者受益于靶向辅助治疗(基于 MTOR 抑制剂),8 个月的随访未发现 TP53、ATR 和 TSC1 突变的 IV 级 PEComa 复发。
我们报告了 2 例具有不同临床病理特征的转移性 PEComa 病例。PEComa 和平滑肌肿瘤的特征之间仍然存在重叠。目前,尚无已知的特征性发现或特定的诊断标志物。